Cargando…
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus
BACKGROUND: Diabetes mellitus (DM) increases the risk of TB disease and poor treatment outcomes such as delayed sputum culture conversion due to inadequate drug exposure. Therapeutic drug monitoring (TDM) has improved these outcomes in some settings. METHODS: To compare treatment outcomes in program...
Autores principales: | Alkabab, Y., Warkentin, J., Cummins, J., Katz, B., Denison, B. M., Bartok, A., Khalil, A., Young, L. R., Timme, E., Peloquin, C. A., Ashkin, D., Houpt, E. R., Heysell, S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union Against Tuberculosis and Lung Disease
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904402/ https://www.ncbi.nlm.nih.gov/pubmed/36853114 http://dx.doi.org/10.5588/ijtld.22.0448 |
Ejemplares similares
-
Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
por: Heysell, Scott K., et al.
Publicado: (2015) -
2354. Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for rifampin-resistant or treatment-intolerant TB disease
por: Haley, Connie A, et al.
Publicado: (2022) -
Early interventions for diabetes related tuberculosis associate with hastened sputum microbiological clearance in Virginia, USA
por: Alkabab, Yosra, et al.
Publicado: (2017) -
Therapeutic Drug Monitoring for Slow Response to Tuberculosis Treatment in a State Control Program, Virginia, USA
por: Heysell, Scott K., et al.
Publicado: (2010) -
Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring
por: Ashkin, Alex, et al.
Publicado: (2023)